×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CDNA – caredx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CDNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
07:08 am
cdna
CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/18
07:05 am
cdna
CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
12/11
07:22 am
cdna
TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy [Yahoo! Finance]
Low
Report
TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy [Yahoo! Finance]
12/11
07:22 am
cdna
CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy [Yahoo! Finance]
Low
Report
CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy [Yahoo! Finance]
12/11
07:00 am
cdna
CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
Medium
Report
CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
12/3
11:04 am
cdna
Has CareDx (CDNA) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
Low
Report
Has CareDx (CDNA) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
11/29
10:56 am
cdna
Higher-Than-Anticipated Reimbursement Rates Lifted CareDx (CDNA) [Yahoo! Finance]
Low
Report
Higher-Than-Anticipated Reimbursement Rates Lifted CareDx (CDNA) [Yahoo! Finance]
11/15
10:47 am
cdna
After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA) [Yahoo! Finance]
Low
Report
After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA) [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/6
04:32 pm
cdna
Form 4 CareDx, Inc. For: Dec 04 Filed by: Novack Jeffrey Adam
Low
Report
Form 4 CareDx, Inc. For: Dec 04 Filed by: Novack Jeffrey Adam
12/4
04:42 pm
cdna
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
Medium
Report
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
12/3
08:55 pm
cdna
Form 4 CareDx, Inc. For: Nov 26 Filed by: Maag Peter
Medium
Report
Form 4 CareDx, Inc. For: Nov 26 Filed by: Maag Peter
12/3
04:31 pm
cdna
Form 4 CareDx, Inc. For: Nov 18 Filed by: Novack Jeffrey Adam
Medium
Report
Form 4 CareDx, Inc. For: Nov 18 Filed by: Novack Jeffrey Adam
11/26
04:25 pm
cdna
Form 144 CareDx, Inc. Filed by: Maag Peter
Low
Report
Form 144 CareDx, Inc. Filed by: Maag Peter
11/25
04:46 pm
cdna
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
Low
Report
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
11/18
05:12 pm
cdna
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
Low
Report
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
11/14
05:14 pm
cdna
Form SC 13G/A CareDx, Inc. Filed by: Bellevue Asset Management (UK) Ltd.
Low
Report
Form SC 13G/A CareDx, Inc. Filed by: Bellevue Asset Management (UK) Ltd.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
17.3%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
TOP News Decliners
3/16
Form 4 CareDx, Inc. For: Mar 16 Filed by: Maag Peter
-19.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: